https://www.pharmacytimes.com/view/rollout-of-long-acting-cabotegravir-without-delay-can-have-greatest-impact-on-hiv-prep
0
0
7/19/23 at 4:20pm
Organization
Pharmacytimes.com
38 words
0
Comments
Investigators said pre-exposure prophylaxis rollout is efficient in settings with high HIV incidence, but not in settings with low HIV incidence.
You are the first to view
Create an account
or login to join the discussion